Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
wikitox:supportive_care [2024/05/07 00:10] – kharris | wikitox:supportive_care [2025/02/17 00:34] (current) – kharris | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | < | + | ====== |
---- | ---- | ||
Management of toxicology patients often focuses on the more ' | Management of toxicology patients often focuses on the more ' | ||
+ | |||
+ | ---- | ||
+ | |||
+ | ===== Airway and Breathing Support ===== | ||
+ | |||
+ | Compromise of either airway or breathing following poisoning normally occurs either as a result of hypoventilation due to respiratory depression or airway obstruction due to central nervous system depression. This can occur following the ingestion of many sedative agents. | ||
+ | |||
+ | Ingestion of caustic agents can also lead to direct airway injury and obstruction - intubation in this group may be difficult and may require involvement of specialist teams (i.e. ENT, anaesthetics). | ||
+ | |||
+ | Endotracael intubation should be performed in patients who are unable to maintain their airway or have respiratory compromise (hypoxia or hypercapnia). The ultimate decision to intubate a sedated patient is based on bedside assessment. GCS alone is a poor predictor of need for airway support in poisoned patients (unlike in head trauma, for which it was developed). | ||
+ | |||
+ | Most experienced toxicologists would be happy to manage a patient with a motor score of 5 or above, unintubated, | ||
+ | |||
+ | It is often prudent to manage patients with decreased level of consciouness, | ||
+ | |||
+ | ---- | ||
+ | |||
+ | ===== Circulatory Support ===== | ||
+ | |||
+ | There are multiple potential mechanisms by which poisoning can cause cirulatory compromise including: vasodilatation, | ||
+ | |||
+ | The decision to treat low bloods pressure in poisoned patients should be based on the presence of hypotension and evidence of hypoperfusion (e.g. CNS compromise, decrease urine output, elevated lactate). In most cases a Mean Arterial Pressure (MAP) of 65mmHg or above is an appropriate target. | ||
+ | |||
+ | In most instances, first-line treatment should be with volume expansion using intravenous crystalloid such as 20-40ml/kg 0.9% Sodium Chloride (max 2L). In patients with known heart or kidney failure or who are elderly it is best to use smaller boluses and assess both ongoing response and evidence of fluid overload. | ||
+ | |||
+ | If a patient continues to show evidence of hypoperfusion despite adequate fluid loading then they will require inotropic or vasopressor support. The decision of which agent to use will depend on the known toxicity of the agent(s) taken but is also greatly aided by bedside echocardigram which can help differentiate between vasoplegia or reduced cardiac contractility being the predominant cause. | ||
+ | < | ||
+ | < | ||
+ | < | ||
+ | < | ||
+ | |||
+ | Advice regarding the use of specific agents for sepcific ingestions can be found in the drug monographs. | ||
---- | ---- | ||
Line 9: | Line 41: | ||
===== Hydration ===== | ===== Hydration ===== | ||
- | Hydration can be compromised for a number of reasons in poisoned patients. Agents can cause vomiting and/or diarrhoea (e.g. lithium, colchicine) either from direct gastric irriation or via stimulation of the vomiting centres leading to increased losses. It is also common for agents to cause a reduced level of consciousness impariring the maintainance of normal fluid intake. | + | Hydration can be compromised for a number of reasons in poisoned patients. |
+ | |||
+ | Agents can cause vomiting and/or diarrhoea (e.g. lithium, colchicine) either from direct gastric irriation or via stimulation of the vomiting centres leading to increased losses. It is also common for agents to cause a reduced level of consciousness, impariring the maintainance of normal fluid intake. | ||
+ | |||
+ | With renal clearance being an important factor in the elimination of many drugs from the body, the development of renal injury may increase the severity or duration of the experienced toxicity. Develoipment of dehyration may also lead to hypotension and increase the risk of thromboembolism. | ||
+ | < | ||
+ | < | ||
+ | |||
+ | In patients with sedation or anticholinergic effects it is important to consider urinary retension and | ||
+ | < | ||
+ | |||
+ | ---- | ||
+ | |||
+ | ===== Thromboprophylaxis and pressure area care ===== | ||
+ | |||
+ | Sedated toxicology patients are at increased risk of both thrombosis and pressure injuries. | ||
+ | |||
+ | In patients who had deep or prolonged sedation, | ||
+ | < | ||
+ | < | ||
+ | |||
+ | ---- | ||
+ | |||
+ | ===== Behavioural Management ===== | ||
+ | |||
+ | Agitation is common in patients being managed post overdose. This may be behavioural in origin or more commonly related to drug effects such as stimulants or drug induced delirium. | ||
+ | |||
+ | No pharmacological management should be employed in all patients including factors such as providing a low stimulus environment, | ||
- | With renal clearance being an important factor in the elimination of drugs from the body, the development of renal injury may increase the severity or duration of the experienced toxicity. Develoipment of dehyration may also lead to hypotension | + | Despite these measures it is often necessary |
- | Maintain adequate hydration in maintained in all toxicology patients, taking into account fluids losses and maintainance fluid requirements. Ensure that electrolytes are maintained at appropriate levels - especially important when considering specific toxicity (e.g. agents causing cardiac toxicity, [[: | + | * **Benzodiazepines** |
+ | * **Antipsychotics** | ||
+ | Cholinestease inhibitors are more effective at relieveing delirium than sedation alone in those that have ingested anticholinergic agents. There use is discussed in more detail in the section on anticholinergic delirium. | ||